Site Management/Investigator Payments Featured Articles
-
IQVIA GrantPlan Questions And Answers
4/27/2023
IQVIA GrantPlan experts recently discussed how to use benchmark data to create fair market value budgets, given sky-rocketing inflation and attrition rates.
-
Any Successful Strategy For Retaining Quality CRCs Must Address Pay, Flexibility, And This Key Relationship
4/26/2023
While poor salary, work flexibility, and professional advancement opportunities bubble to the top of potential reasons why turnover is high among CRCs, one of the real measures of retention and success is the relationship between the clinical research coordinator and this mentor.
-
DCTs And Sites: What Sponsors Need To Know
4/21/2023
Clinical Leader Live held a webinar last August with three decentralized clinical trial (DCT) experts to discuss the history, challenges, costs, and staffing issues surrounding DCTs. Guests Jimmy Bechtel, VP of site engagement for the Society of Clinical Research Sites (SCRS); Brad Hightower, CEO of Hightower Clinical; and Karri Venn, COO, president, and chair of the operating board at Centricity Research, lent their expertise and answered questions from the audience.
-
Sites Look To Unravel The Tech Tangle Of DCTs
2/28/2023
Decentralized clinical trials and all their elements are touted as flexible options for patients. But what about the sites carrying them out? Jimmy Bechtel of the Society for Clinical Research Sites (SCRS) says sites are looking for clarity and consistency when it comes to the tech being thrust upon them by sponsors and CROs.
-
The Value Of ClinCard And ConneX: A Site Perspective
2/17/2023
Often, the frequent visits associated with participating in a clinical research trial can create additional burden on patients. Read about a clinician's site experience.
-
The Secret(s) To Solving The Clinical Trials Staffing Crisis
2/10/2023
In September 2022, there were 6.6 million clinical research jobs posted in the U.S. but only 5.7 million available hires. What accounts for the hiring gap, and how can it be narrowed? Kathi Enderes, SVP, research, and global industry analyst, at The Josh Bersin Company explains why looking outside the field is one way to address worker shortages.
-
The 8 Key Takeaways For FDA Inspections In The Food And Drug Omnibus Reform Act
2/7/2023
With President Biden’s signature, the Food and Drug Omnibus Reform Act of 2022 (FDORA), part of the larger Consolidated Appropriations Act of 2023, became law on Dec. 29, 2022. FDORA expands and modifies the inspection authority of the FDA in several key areas, including alternative tools to inspection, mutual recognition agreements, bioresearch monitoring, and more.
-
How Flexibility Can Strengthen The Sponsor-Site Relationship
1/25/2023
In 2020, Freenome launched PREEMPT CRC to test the early diagnosis of colorectal cancer using a multiomics platform. Leveraging key soft skills like flexibility and respect for others' differences, Freenome successfully enrolled more than 40,000 patients across 200+ sites.
-
Clinical Sites Are Optimistic, Despite Growing Challenges
1/17/2023
The last few years have not been easy for sites involved with conducting clinical research. The onset of the pandemic in 2020 created numerous challenges, including the implementation of new technologies and operating models, the leveraging of remote staff, and virtual facilities. Despite the ongoing challenges, global sites remain optimistic about the future of clinical trials.
-
How Can Clinical Research Better Navigate Healthcare Deserts?
1/17/2023
Large swaths of the U.S. remain healthcare deserts, where access to clinical sites, pharmacies, and hospitals is limited. This contributes to underrepresentation in clinical research. What are the roles of technology and community outreach, and what are some current industry efforts to address it?